Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Amifostine, a Radioprotectant Agent, Protects Rat Hepatic Microsomal Membranes Against Ionizing Radiation Induced Damage
Date
2009-02-01
Author
Cakmak, Gulgun
Severcan, Mete
Zorlu, Faruk
Severcan, Feride
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
59
views
0
downloads
Cite This
URI
https://hdl.handle.net/11511/55381
Journal
BIOPHYSICAL JOURNAL
Collections
Department of Biology, Article
Suggestions
OpenMETU
Core
Amifostine, a radioprotectant agent, protects rat brain tissue lipids against ionizing radiation induced damage: An FTIR microspectroscopic imaging study
Cakmak, Gulgun; Miller, Lisa M.; Zorlu, Faruk; Severcan, Feride (Elsevier BV, 2012-04-15)
Amifostine is the only approved radioprotective agent by FDA for reducing the damaging effects of radiation on healthy tissues. In this study, the protective effect of amifostine against the damaging effects of ionizing radiation on the white matter (WM) and grey matter (GM) regions of the rat brain were investigated at molecular level. Sprague-Dawley rats, which were administered amifostine or not, were whole-body irradiated at a single dose of 800 cGy, decapitated after 24 h and the brain tissues of these...
Poly (Dl-Lactic-Co-Glycolic Acid) microparticles and synthetic peptide drug conjugate for anti-cancer drug delivery
Şen, Gülseren Petek; Gündüz, Ufuk; Department of Biotechnology (2009)
Cancer is a group of diseases in which normal cells are converted to cells capable of autonomous growth and invasion. In the chemotherapeutic control of cancer, drugs are usually given systemically so they reach toxic levels in healthy cells as well as cancer cells. This causes serious side effects. Another important problem with chemotherapy is resistance developed to cytotoxic drugs (multi drug resistance). Doxorubicin (Dox) occupies a central position in the treatment of breast cancer. However doxorubici...
Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials
KALAFAT, ERKAN; ŞÜKÜR, YAVUZ EMRE; Abdi, A.; Thilaganathan, B.; Khalil, A. (2018-12-01)
Objective Metformin has been reported to reduce the risk of pre-eclampsia. It is also known to influence soluble fms-like tyrosine kinase-1 level, which correlates significantly with the gestational age at onset and severity of pre-eclampsia. The main aim of this systematic review and meta-analysis of randomized trials was to determine whether metformin use is associated with the incidence of hypertensive disorders of pregnancy (HDP).
Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer
Hua, Serenus; Williams, Cynthia C.; Dimapasoc, Lauren M.; Ro, Grace S.; Özcan Kabasakal, Süreyya; Miyamoto, Suzanne; Lebrilla, Carlito B.; An, Hyun Joo; Leiserowitzf, Gary S. (Elsevier BV, 2013-03-01)
Aberrant glycosylation has been observed for decades in essentially all types of cancer, and is now well established as an indicator of carcinogenesis. Mining the glycome for biomarkers, however, requires analytical methods that can rapidly separate, identify, and quantify isomeric glycans. We have developed a rapid-throughput method for chromatographic glycan profiling using microfluidic chip-based nanoflow liquid chromatography (nano-LC)/mass spectrometry. To demonstrate the utility of this method, we ana...
Paclitaxel suppresses Tau-mediated microtubule bundling in a concentration-dependent manner.
Choi, MC; Chung, PJ; Song, C; Miller, HP; Kiriş, Erkan; Li, Y; Wilson, L; Feinstein, SC; Safinya, CR (2017-01-01)
Background: Microtubules (MTs) are protein nanotubes comprised of straight protofilaments (PFs), head to tail assemblies of alpha beta-tubulin heterodimers. Previously, it was shown that Tau, a microtubule-associated protein (MAP) localized to neuronal axons, regulates the average number of PFs in microtubules with increasing inner radius <R-in(MT)> observed for increasing Tau/tubulin-dimer molar ratio Phi(Tau) at paclitaxel/tubulin-dimer molar ratio Lambda(ptxl) = 1/1. Methods: We report a synchrotron SAX...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
G. Cakmak, M. Severcan, F. Zorlu, and F. Severcan, “Amifostine, a Radioprotectant Agent, Protects Rat Hepatic Microsomal Membranes Against Ionizing Radiation Induced Damage,”
BIOPHYSICAL JOURNAL
, pp. 0–0, 2009, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/55381.